-
Proportion of CRC Diagnoses Increased in Adults Younger Than 50
drugs
July 23, 2019
From 2004 to 2015, there was an increase in the proportion of persons diagnosed with colorectal cancer (CRC) at an age younger than 50 years in the United States...
-
Oral Aspirin Does Not Up FIT Test Sensitivity for ID'ing CRC
drugs
May 08, 2019
Oral Aspirin Does Not Up FIT Test Sensitivity for ID'ing CRC.
-
Oral Aspirin Does Not Up FIT Test Sensitivity for ID'ing CRC
drugs
May 08, 2019
Administration of a single dose of oral aspirin prior to fecal immunochemical testing does not increase test sensitivity for detecting advanced colorectal neoplasms, according to a study published in the May 7 issue of the Journal of the American Medical
-
Some Patients With Imminently Fatal Cancer Undergo Treatment
drugs
April 18, 2019
Some patients with imminently fatal de novo metastatic cancer undergo treatment.
-
Evotec & Indivumed Enter Research Collaboration
ontractpharma
April 15, 2019
To discover and develop first-in-class therapeutics for the treatment of colorectal cancer.
-
Single-Application FIT Moderately Sensitive, Specific for CRC
drugs
February 26, 2019
Single-application fecal immunochemical tests (FITs) have moderate-to-high sensitivity and specificity for colorectal cancer (CRC), according to a review published online Feb. 26 in the Annals of Internal Medicine.
-
Type 2 Diabetes Linked to Colorectal Cancer Risk in Men
drugs
December 06, 2018
Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the British Journal of Cancer.....